Wuhan East Lake High Technology
VC Fund
Wuhan, China
Wuhan East Lake High Technology is an urban development company. They also provide environmental engineering, park operations, urban development, construction, and engineering consulting services.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Wuhan East Lake High Technology invests in
Stages Wuhan East Lake High Technology invests in
Countries Wuhan East Lake High Technology invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Liao Tong
|
|||
4 more contacts available
Investment Focus
Industry
- Medical 1 (25%)
- Genetics 1 (25%)
- Robotics 1 (25%)
- Biotechnology 1 (25%)
- Manufacturing 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
- Funding Round 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Liao Tong
General Manager
|
General Manager | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sano Dynamics
|
Sano Dynamics is a producer of hydraulic system core components and hydraulic industrial robots. | Series B / Mar 02, 2026 | |
|
Migos Medical
|
Migos Medical is an innovative medical device company specializing in minimally invasive ophthalmology. Its core technology is based on active cationic polymerization biomaterial technology, which likely enables advanced biomaterials for ophthalmic applications. | Series A / May 20, 2025 | |
Gene Vector
|
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,etc. | Jan 03, 2025 | |
|
Gene Vector
|
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,etc. | $3.2M / Seed / Mar 10, 2022 |
Co-Investors
Guangzhou Financial Holding Fund Management
1 deal together
Ming capital
1 deal together
Si Chuan Venture Capital
1 deal together
Yingke Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Wuhan East Lake High Technology invest in?
Wuhan East Lake High Technology invests primarily in Medical, Genetics and Robotics startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wuhan East Lake High Technology?
Public channels for Wuhan East Lake High Technology include the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wuhan East Lake High Technology?
The team at Wuhan East Lake High Technology includes Liao Tong (General Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
